Position in QGEN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,832,430
New position
Shares Held
45,765
first reported quarter
Ownership
0.022%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Jump Financial, LLC holds $46,627,937 across 11 Diagnostics & Research names. QGEN ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
204,128 | $23,266,509 | |
| 2 | DHR |
Danaher Corp /De/
|
35,519 | $6,734,400 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
12,319 | $6,055,156 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
5,430 | $3,051,062 | |
| 5 | GH |
Guardant Health, Inc.
|
26,500 | $2,447,805 | |
| 6 | QGEN |
Qiagen N.V.
This page
|
45,765 | $1,832,430 | |
| 7 | FLGT |
Fulgent Genetics, Inc.
|
71,839 | $1,142,240 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
1,920 | $921,964 |
All Filings in QGEN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,832,430 | 45,765 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||